HOB Biotech Group Corp.,Ltd (SHA:688656)
China
· Delayed Price · Currency is CNY 87.16
-3.25 (-3.59%)
May 21, 2025, 2:45 PM CST
SHA:688656 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | 34.63 | 36.8 | 47.33 | 41.65 | 86.19 | 56.62 | Upgrade
|
| Depreciation & Amortization | 44.53 | 44.53 | 39.52 | 32.53 | 24.53 | 15.4 | Upgrade
|
| Other Amortization | 9.65 | 9.65 | 7.82 | 5.26 | 1.5 | 1.15 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.1 | 0.1 | -0.13 | 0.36 | -0.12 | -0.08 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.75 | 1.75 | 0.1 | 0.11 | 0.2 | 0.45 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.19 | -0.19 | -2.21 | -6.07 | -12.13 | -14.89 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.38 | 0.38 | 0.5 | -0.26 | 0.41 | 0.52 | Upgrade
|
| Other Operating Activities | 1.52 | 3.07 | 2.64 | 2.23 | 1.76 | 1.88 | Upgrade
|
| Change in Accounts Receivable | -2.83 | -2.83 | -7.83 | -0.41 | -1.32 | -13.02 | Upgrade
|
| Change in Inventory | -0 | -0 | -23.42 | -19.6 | -6.26 | -2.32 | Upgrade
|
| Change in Accounts Payable | 9.61 | 9.61 | 35.76 | 1.43 | 10.69 | 10.88 | Upgrade
|
| Change in Other Net Operating Assets | - | - | 3.35 | 1.26 | - | - | Upgrade
|
| Operating Cash Flow | 97.49 | 101.22 | 102.69 | 58.31 | 104.79 | 58.22 | Upgrade
|
| Operating Cash Flow Growth | -9.98% | -1.44% | 76.13% | -44.36% | 79.98% | -15.10% | Upgrade
|
| Capital Expenditures | -113.1 | -155.37 | -178.03 | -220.21 | -167.89 | -57.01 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.55 | 0.55 | 1.04 | 0.5 | 1.37 | 1.4 | Upgrade
|
| Investment in Securities | -0.04 | 0.19 | 137.44 | -124.15 | - | 20.58 | Upgrade
|
| Other Investing Activities | 0.87 | 0.87 | - | - | 12.12 | - | Upgrade
|
| Investing Cash Flow | -111.72 | -153.76 | -39.55 | -343.86 | -154.39 | -35.03 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 50 | 20 | - | Upgrade
|
| Long-Term Debt Issued | - | 145 | 50 | 0.2 | - | 60 | Upgrade
|
| Total Debt Issued | 135 | 145 | 50 | 50.2 | 20 | 60 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -20 | -43.96 | - | Upgrade
|
| Long-Term Debt Repaid | - | -86.06 | -75 | -6.38 | -6.66 | -66.06 | Upgrade
|
| Total Debt Repaid | -98.06 | -86.06 | -75 | -26.38 | -50.62 | -66.06 | Upgrade
|
| Net Debt Issued (Repaid) | 36.94 | 58.94 | -25 | 23.82 | -30.62 | -6.06 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 491.47 | - | Upgrade
|
| Repurchase of Common Stock | -20.01 | -20.01 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -28.64 | -28.17 | -20.79 | -34.68 | -19.8 | -49.19 | Upgrade
|
| Other Financing Activities | 1.4 | - | -7.33 | - | - | - | Upgrade
|
| Financing Cash Flow | -10.31 | 10.76 | -53.12 | -10.85 | 441.05 | -55.25 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.32 | -0.06 | 0.14 | -0.14 | -0.41 | 0.12 | Upgrade
|
| Net Cash Flow | -24.22 | -41.84 | 10.16 | -296.55 | 391.04 | -31.95 | Upgrade
|
| Free Cash Flow | -15.61 | -54.15 | -75.34 | -161.9 | -63.09 | 1.21 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | -96.41% | Upgrade
|
| Free Cash Flow Margin | -3.96% | -13.46% | -19.10% | -50.53% | -19.86% | 0.55% | Upgrade
|
| Free Cash Flow Per Share | -0.26 | -0.85 | -1.18 | -2.56 | -1.02 | 0.03 | Upgrade
|
| Cash Income Tax Paid | 41.91 | 45.29 | 40.91 | 32.9 | 37.85 | 24.3 | Upgrade
|
| Levered Free Cash Flow | -37.76 | -48.66 | -143.14 | -138.42 | -87.75 | -59 | Upgrade
|
| Unlevered Free Cash Flow | -35.9 | -46.96 | -141.56 | -137.22 | -86.98 | -57.82 | Upgrade
|
| Change in Net Working Capital | 12.1 | -17.1 | 47.04 | -17.69 | -2.16 | 48.75 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.